Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AMICUS THERAPEUTICS, INC. Director's Dealing 2016

Sep 8, 2016

31523_dirs_2016-09-08_c630394a-2bb4-4cae-ab82-126d3430fd21.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2016-09-06

Reporting Person: Do Hung (Chief Science Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-09-06 Common Stock S 25000 $7.00 Disposed 583453 Direct

Footnotes

F1: The sales of shares of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2016.